Sehwag replies to Kargil martyr’s daughter's anti-ABVP post

Kalaburagi, Mar 16: In the wake of coronavirus scare, the public gatherings including local markets, village fairs, Urs festival in Kalaburagi district have been banned, said B Sharat, Deputy Commissioner, on Sunday.

"Gatherings including local markets, village fairs, Urs festival in the district have been banned as a precautionary measure against the coronavirus until further orders," Sharat said.

The World Health Organization (WHO) has declared that Europe has become the new 'epicenter' of the global coronavirus pandemic that has infected more than 15 lakh people with over 4,000 deaths globally.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Bengaluru, Jul 16: Amid difficulties being faced by COVID-19 patients in getting beds, the Karnataka government on Wednesday made bed allocation display board mandatory in all hospitals registered under Karnataka Private Medical Establishment (KPME).

"It is made mandatory that all hospitals registered under KPME in Karnataka State should display at the reception counter, a bed allocation display board," a notification issued by the state government read.

"It should display the name of the hospital, the total number of beds (as per of KPME registration) and the total number of beds allocated for COVID-19 patients referred by Bruhat Bengaluru Mahanagara Palike (BBMP)," it said.

The notification further stressed that the data must corroborate with the data of the central bed allocation system of BBMP. The display board should be arranged by July 16.

Non-compliance to the order issued by the state government will attract punishment under relevant sections of the Disaster Management Act 2005 and Indian Penal Code, the order read.

The state government on June 23 issued a notification making it mandatory to reserve 50 per cent of the beds in private hospitals to treat COVID-19 patients referred by public health authorities.